Frequency of First Generic Drug Approvals With “Skinny Labels” in the United States

Eitemau Tebyg

• Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
  gan: Sarpatwari, Ameet, et al.
  Cyhoeddwyd: (2015)
• Regulatory Solutions to the Problem of High Generic Drug Costs
  gan: Luo, Jing, et al.
  Cyhoeddwyd: (2015)
• The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
  gan: Sarpatwari, Ameet, et al.
  Cyhoeddwyd: (2016)
• Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions
  gan: Sacks, Chana A., et al.
  Cyhoeddwyd: (2020)
• Federal Spending on Off-Patent Drugs That Lack Generic Competition
  gan: Rome, Benjamin N., et al.
  Cyhoeddwyd: (2020)